Morrow Sodali advisor on the Pfizer - Medivation acquisition

Morrow Sodali will act as Information Agent in the Pfizer - Medivation M&A deal.

The Companies have entered into a definitive merger agreement under which Pfizer will acquire Medivation, a biopharmaceutical company focused on developing and commercializing small molecules for oncology, for $81.50 a share in cash for a total enterprise value of approximately $14 billion.